Anaïse B.
- Country
- France
- Department
- d'Oncologie-Hématologie
Research Overview
Data & Insights
Has run more than one trial at 19 of 58 partner sites.
Specializations
Myelodysplastic Syndromes (MDS)
The investigator specializes in both low-risk and high-risk myelodysplastic syndromes, with particular emphasis on developing innovative therapeutic approaches. Their research encompasses treatment strategies for patients with varying risk profiles, including those without ring sideroblasts and cases unresponsive to conventional therapies.
- Treatment-resistant MDS
- Novel combination therapies
- Risk-stratified treatment approaches
Areas of focus include erythroid response optimization and management of transfusion dependency in MDS patients.
Myeloproliferative Neoplasms
The investigator conducts research in Philadelphia-negative myeloproliferative neoplasms, focusing on thromboembolic complication prevention. Their work encompasses various MPNs including polycythemia vera, essential thrombocythemia, and myelofibrosis.
- Thromboembolic prevention strategies
- JAK2V617F-positive disease management
- Novel anticoagulation approaches
The research extends to comparative studies of anticoagulation strategies in high-risk MPN patients.
Therapeutic Innovation
The investigator explores novel therapeutic combinations for hematologic malignancies, with particular attention to drug combinations that may enhance treatment outcomes. Their work includes evaluation of targeted therapies and their integration with established treatment protocols.
- Combination therapy development
- Clinical efficacy assessment
- Treatment optimization strategies
Focus areas include the development of new therapeutic approaches for previously treated and newly diagnosed patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.